Literature DB >> 26828137

Oxidative stress markers are elevated in exhaled breath condensate of workers exposed to nanoparticles during iron oxide pigment production.

Daniela Pelclova1, Vladimir Zdimal, Petr Kacer, Zdenka Fenclova, Stepanka Vlckova, Kamila Syslova, Tomas Navratil, Jaroslav Schwarz, Nadezda Zikova, Hana Barosova, Francesco Turci, Martin Komarc, Tomas Pelcl, Jaroslav Belacek, Jana Kukutschova, Sergey Zakharov.   

Abstract

Markers of oxidative stress and inflammation were analysed in the exhaled breath condensate (EBC) and urine samples of 14 workers (mean age 43  ±  7 years) exposed to iron oxide aerosol for an average of 10  ±  4 years and 14 controls (mean age 39  ±  4 years) by liquid chromatography-electrospray ionization-mass spectrometry/mass spectrometry (LC-ESI-MS/MS) after solid-phase extraction. Aerosol exposure in the workplace was measured by particle size spectrometers, a scanning mobility particle sizer (SMPS) and an aerodynamic particle sizer (APS), and by aerosol concentration monitors, P-TRAK and DustTRAK DRX. Total aerosol concentrations in workplace locations varied greatly in both time and space. The median mass concentration was 0.083 mg m(-3) (IQR 0.063-0.133 mg m(-3)) and the median particle concentration was 66 800 particles cm(-3) (IQR 16,900-86,900 particles cm(-3)). In addition, more than 80% of particles were smaller than 100 nm in diameter. Markers of oxidative stress, malondialdehyde (MDA), 4-hydroxy-trans-hexenale (HHE), 4-hydroxy-trans-nonenale (HNE), 8-isoProstaglandin F2α (8-isoprostane) and aldehydes C6-C12, in addition to markers of nucleic acid oxidation, including 8-hydroxy-2-deoxyguanosine (8-OHdG), 8-hydroxyguanosine (8-OHG), 5-hydroxymethyl uracil (5-OHMeU), and of proteins, such as o-tyrosine (o-Tyr), 3-chlorotyrosine (3-ClTyr), and 3-nitrotyrosine (3-NOTyr) were analysed in EBC and urine by LC-ESI-MS/MS. Almost all markers of lipid, nucleic acid and protein oxidation were elevated in the EBC of workers comparing with control subjects. Elevated markers were MDA, HNE, HHE, C6-C10, 8-isoprostane, 8-OHdG, 8-OHG, 5-OHMeU, 3-ClTyr, 3-NOTyr, o-Tyr (all p  <  0.001), and C11 (p  <  0.05). Only aldehyde C12 and the pH of samples did not differ between groups. Markers in urine were not elevated. These findings suggest the adverse effects of nano iron oxide aerosol exposure and support the utility of oxidative stress biomarkers in EBC. The analysis of urine oxidative stress biomarkers does not support the presence of systemic oxidative stress in iron oxide pigment production workers.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26828137     DOI: 10.1088/1752-7155/10/1/016004

Source DB:  PubMed          Journal:  J Breath Res        ISSN: 1752-7155            Impact factor:   3.262


  18 in total

Review 1.  Biological monitoring of workers exposed to engineered nanomaterials.

Authors:  P Schulte; V Leso; M Niang; I Iavicoli
Journal:  Toxicol Lett       Date:  2018-06-18       Impact factor: 4.372

2.  Inhalation exposure to silver nanoparticles induces hepatic inflammation and oxidative stress, associated with altered renin-angiotensin system signaling, in Wistar rats.

Authors:  Subhayu Nayek; Amie K Lund; Guido F Verbeck
Journal:  Environ Toxicol       Date:  2021-11-18       Impact factor: 4.119

3.  Modulation of Pulmonary Toxicity in Metabolic Syndrome Due to Variations in Iron Oxide Nanoparticle-Biocorona Composition.

Authors:  Li Xia; Saeed Alqahtani; Christina R Ferreira; Uma K Aryal; Katelyn Biggs; Jonathan H Shannahan
Journal:  Nanomaterials (Basel)       Date:  2022-06-11       Impact factor: 5.719

Review 4.  Evolution of clinical and environmental health applications of exhaled breath research: Review of methods and instrumentation for gas-phase, condensate, and aerosols.

Authors:  M Ariel Geer Wallace; Joachim D Pleil
Journal:  Anal Chim Acta       Date:  2018-02-09       Impact factor: 6.558

5.  Iron Oxide Nanoparticle-Induced Neoplastic-Like Cell Transformation in Vitro Is Reduced with a Protective Amorphous Silica Coating.

Authors:  Tiffany G Kornberg; Todd A Stueckle; Jayme Coyle; Raymond Derk; Philip Demokritou; Yon Rojanasakul; Liying W Rojanasakul
Journal:  Chem Res Toxicol       Date:  2019-11-11       Impact factor: 3.739

6.  8-Hydroxydeoxyguanosine as a biomarker of oxidative DNA damage in workers exposed to low-dose benzene.

Authors:  Concettina Fenga; Silvia Gangemi; Michele Teodoro; Venerando Rapisarda; Kirill Golokhvast; Anca Oana Docea; Aristidis M Tsatsakis; Chiara Costa
Journal:  Toxicol Rep       Date:  2017-05-31

7.  Investigating the relationship between particulate matter and inflammatory biomarkers of exhaled breath condensate and blood in healthy young adults.

Authors:  Morteza Seifi; Noushin Rastkari; Mohammad Sadegh Hassanvand; Kazem Naddafi; Ramin Nabizadeh; Shahrokh Nazmara; Homa Kashani; Ahad Zare; Zahra Pourpak; Seyed Yaser Hashemi; Masud Yunesian
Journal:  Sci Rep       Date:  2021-06-21       Impact factor: 4.379

Review 8.  Potential Toxicity and Underlying Mechanisms Associated with Pulmonary Exposure to Iron Oxide Nanoparticles: Conflicting Literature and Unclear Risk.

Authors:  Tiffany G Kornberg; Todd A Stueckle; James A Antonini; Yon Rojanasakul; Vincent Castranova; Yong Yang; Liying Wang
Journal:  Nanomaterials (Basel)       Date:  2017-10-06       Impact factor: 5.076

9.  Reference Ranges of 8-Isoprostane Concentrations in Exhaled Breath Condensate (EBC): A Systematic Review and Meta-Analysis.

Authors:  Yara Shoman; Pascal Wild; Maud Hemmendinger; Melanie Graille; Jean-Jacques Sauvain; Nancy B Hopf; Irina Guseva Canu
Journal:  Int J Mol Sci       Date:  2020-05-28       Impact factor: 5.923

10.  Deep Airway Inflammation and Respiratory Disorders in Nanocomposite Workers.

Authors:  Daniela Pelclova; Vladimir Zdimal; Martin Komarc; Stepanka Vlckova; Zdenka Fenclova; Jakub Ondracek; Jaroslav Schwarz; Martin Kostejn; Petr Kacer; Stepanka Dvorackova; Alexey Popov; Pavlina Klusackova; Sergey Zakharov; Dhimiter Bello
Journal:  Nanomaterials (Basel)       Date:  2018-09-16       Impact factor: 5.076

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.